“You have a better game plan than the {others} – and that is the name of the game – to constantly dream of better ways and a better future for those we care about and for our society. We all need to work towards better models of care and better care. I call your game plan “Empowerment Plus”, for it focuses in on empowering the person in pain. The {others} is old wine in new bottles- it is medical corporatism – with a kinder and gentler “bio-psycho-social” face. It isn’t energetic enough or focused enough on people to meet the needs of the pain community. As pain remains very much a mystery, and the prevalence of pain conditions like neuropathic pain and osteoarthritis are on the rise, we all need to strive to overcome the limitations of past ways of thinking about and addressing the needs of people in pain. I know you are a game changer in the pain community and that is what is needed to advance pain care beyond its current great limitations. Until next time, David B.” 2/16/2015
Tag:
foundation
Breast cancer is the most common cancer among American women, where 1 in 8 women in the US will develop breast cancer during their lifetime. The majority of breast cancers are hormone-receptor positive (HR+), which means the cancer cells grow in response to hormones. Such cancers are typically treated with hormonal therapy.
There is a clinical study available, seeking participants who have Breast Cancer in order evaluate whether the study drug combined with hormonal therapy has better outcomes than hormonal therapy alone.
More about the study:
- The investigational drug is administered by oral capsules and the hormonal therapy by injection into your muscle
- At least 193 people have already taken this drug in clinical trials
- There will be 550 participants in this trial
If you are interested, the full study details and eligibility criteria are listed here.
Eligibility Criteria:
Participants must:
- have been diagnosed with breast cancer which expresses at least one hormone receptor (estrogen receptor or progesterone receptor) and is HER2 negative
- have stopped having monthly menstrual cycles either naturally or through surgery or hormonal treatment
Participants must not:
- have received chemotherapy for metastatic disease (neoadjuvant and adjuvant chemotherapy is allowed)
- be currently participating in any other clinical trial
- have a history of central nervous system metastases
Please complete the online questionnaire to check if you’re eligible for the trial.
If you’re not familiar with clinical trials, here are some FAQs:
What are clinical trials?
Clinical trials are research studies to determine whether investigational drugs or treatments are safe and effective for humans. All new investigational medications and devices must undergo several clinical trials, often involving thousands of people.
Why participate in a clinical trial?
You will have access to new investigational treatments that would be available to the general public only upon approval. You will also receive study-related medical care and attention from clinical trial staff at research facilities. Clinical trials offer hope for many people and an opportunity to help researchers find better treatments for others in the future.